The University of North Carolina Hospitals Investigational Drug Services is a clinical research site located in Chapel Hill, North Carolina, United States 27514.
Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
The University of North Carolina Hospitals Investigational Drug Services has participated in 1 clinical trials.
Therapeutic areas: Lupus Erythematosus, Systemic.
Sponsors: Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of North Carolina Hospitals Investigational Drug Services has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of North Carolina Hospitals Investigational Drug Services has 1 clinical trials on record. Their work covers Lupus Erythematosus, Systemic.
The University of North Carolina Hospitals Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.